Effects of different doses of ulinastatin on inflammatory response and pulmonary function after cardiopulmonary bypass

Chinese Critical Care Medicine

Volumn 21, Issue 11, 2009, Pages 664-667

  Yu, Xiang You ^a   Fan, Li Li ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammatory factor; Cardiac valvular replacement; Cardiopulmonary bypass; Lung function; Lung injury; Proinflammatory factor; Ulinastatin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN; ANTIINFLAMMATORY AGENT; GLYCOPROTEIN;

ARTICLE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HEART VALVE REPLACEMENT; HUMAN; INFLAMMATION; LUNG FUNCTION; OXYGEN TENSION; PROTECTION; RANDOMIZED CONTROLLED TRIAL; ADULT; AGED; BLOOD; DRUG EFFECTS; FEMALE; LUNG; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; FEMALE; GLYCOPROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73349099356     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760Zcma.j.issn.1003-0603.2009.11.009     Document Type: Article

References (17)

1. Sakurada T, Kazui T, Tanaka H, et al. Comparative experimental study of cerebral protection during aortic arch reconstruction. Ann Thorac Surg, 1996,61(5):1348-1354.
2. Tanaka H, Kazui T, Sato H, et al. Experimental study on the optimum flow rate and pressure for selective cerebral perfusion. Ann Thorac Surg, 1995,59(3):651-657.
3. Chinese source
4. Chinese source
5. Chinese source
6. Kapoor MC, Ramachandran TR. Inflammatory response to cardiac surgery and strategies to overcome it. Ann Card Anaesth, 2004,7(2):113-128.
7. Heijmans JH, Liem KS, Damoiseaux GM, et al. Pulmonary function and inflammatory markers in patients undergoing coronary revascularisation with or without cardiopulmonary bypass. Anaesthesia, 2007,62(12):1233-1240.
8. Paśnik J, Moll J, Cywińska-Bernas A, et al. Proteolytic and cytokine balance abnormalities in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass. Kardiol Pol, 2007,65(10):1208-1214.
9. Hammer S, Fuchs AT, Rinker C, et al. Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol, 2004,59(6):624-629.
10. Ng CS, Arifi AA, Wan S, et al. Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function. Ann Thorac Surg, 2008,85(1):154-162.
11. Chinese source
12. Chinese source
13. Chinese source
14. Chinese source
15. Xu L, Ren B, Li M, et al. Ulinastatin suppresses systemic inflammatory response following lung ischemia-reperfusion injury in rats. Transplant Proc, 2008,40(5):1310-1311.
16. Chinese source
17. Chinese source